A detailed history of Gamma Investing LLC transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 523 shares of STOK stock, worth $6,929. This represents 0.0% of its overall portfolio holdings.

Number of Shares
523
Previous 253 106.72%
Holding current value
$6,929
Previous $3.42 Million 88.06%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$12.24 - $15.92 $3,304 - $4,298
270 Added 106.72%
523 $6.43 Million
Q2 2024

Jul 02, 2024

BUY
$11.03 - $17.52 $1,500 - $2,382
136 Added 116.24%
253 $3.42 Million
Q1 2024

Apr 05, 2024

BUY
$4.12 - $14.17 $482 - $1,657
117 New
117 $1.58 Million

Others Institutions Holding STOK

About Stoke Therapeutics, Inc.


  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $522M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.